Review Article
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
Table 4
Effects of cannabidiol in animal models of CINP.
| CINP model | Effects | Effects of CB receptor antagonists on the activity of the compound | Reference | Chemotherapy drug | Animal |
| Paclitaxel | Female C57Bl6 mice | Prevented the development of cold and mechanical allodynia | No antagonists were used | [49] | Paclitaxel | Female C57Bl6 mice | Prevented the development of mechanical allodynia | CB1 receptor antagonist SR141716 and | [50] | CB2 receptor antagonist SR144528 had no effects | 5-HT1A receptor antagonist WAY 100635 antagonised | Cisplatin | Male C57BL/6 mice | Suppressed established mechanical allodynia | No antagonists were used | [31] | Did not prevent the development of mechanical allodynia |
|
|